logo
#

Latest news with #ResearchWizard

How to Buy the Best Momentum Stocks Now
How to Buy the Best Momentum Stocks Now

Yahoo

timea day ago

  • Business
  • Yahoo

How to Buy the Best Momentum Stocks Now

The stock market has rallied off its April lows, hitting multiple all-time highs in the process. Investors are often nervous about buying stocks or ETFs at new highs based on the idea that they already missed their chance. But if you never buy stocks or ETFs at or near new highs, you might never buy anything, especially in strong bull markets. Stock market history dating back to 1970 shows that strength leads to more strength. The average 12-month price return for the S&P 500 after reaching an all-time high was 9.1%, while the average price return from investing all other days was 8.7%, according to JPMorgan data. That said, not all stocks have participated in the rally, with roughly 200 S&P 500 stocks in the red in 2025. As the stock market hits new highs, investors should buy stocks that are also hitting new peaks. The stocks the screen puts on your radar have also experienced strong upward earnings revisions activity, earning them a Zacks Rank #1 (Strong Buy). Momentum Stock Screen Basics The screen we are looking into today comes loaded with the Research Wizard. The screen helps investors dig through all of the Zacks Rank #1 (Strong Buy) stocks, of which there are over 200 at any given time, to find some of the top momentum names. The screen narrows down the list of Zacks Rank #1 (Strong Buy) stocksto those with upward price momentum that are also trading within 20% of their 52-week highs. The screen then uses the PEG ratio and the Price to Sales ratio to help make sure investors are getting value as well. The screen then makes your life a little easier and narrows it down to just seven stock picks. The screen basics are listed below… · Zacks Rank = #1 (Strong Buy) · Current Price/52-week High >= 0.8 · PEG Ratio: P/E F(1)/EPS Growth <= 1 · Price/Sales <= 3 · Percentage Change Price -12 Weeks = Top # 7 This strategy comes loaded with the Research Wizard and it is called bt_sow_momentum_method1 It can be found in the SoW (Screen of the Week) folder. The screen is pretty simple, yet powerful. Here is one of the seven stocks that made it through this week's screen… Buy Soaring AI Data Center Stock MOD for Long-Term Growth Modine MOD is a thermal management technology and solutions standout, benefiting from various long-term trends, including AI. MOD designs and makes systems to help heat, cool, and ventilate everything from engines to data centers. Its ability to expand alongside the AI data center boom has fueled impressive earnings growth and a huge charge for MOD stock over the past several years. Modine's portfolio includes heat exchangers, cooling units, thermal management systems, and beyond, helping improve efficiency and performance by controlling temperatures in all kinds of machines. MOD averaged 9.4% revenue growth in the past four years and 50% adjusted EPS expansion in the trailing three. Image Source: Zacks Investment Research The thermal management giant posted a huge beat-and-raise Q1 of fiscal 2026 at the end of July. MOD is projected to grow its sales by over 11% in FY26 and 14% next year to reach $3.28 billion, boosted by 'continued momentum and higher sales of data center products, along with organic and inorganic growth in the HVAC Technologies product group.' Its FY27 earnings estimate has jumped 8% since its July 30 release, with Modine projected to grow its earnings by 14% this year and 31% next year. Plus, its upbeat EPS revisions earn it a Zacks Rank #1 (Strong Buy) and reverse its recent downward trend. Image Source: Zacks Investment Research MOD surged after its release back up to its all-time highs from late 2024 and early 2025. The stock has gained a whopping 750% in the past three years. Its recent charge has Modine neck-and-neck with the S&P 500 over the past 25 years, and it's crushed its industry. Despite sitting right below its all-time highs, Modine trades 11% below its average Zacks price target, and it completed the bullish golden cross (50-day MA moving above the 200-day) earlier this month. Long-term investors should consider buying the thermal management stock that Wall Street loves (all seven of the brokerage recommendations Zacks has for Modine are 'Strong Buys'). Get the rest of the stocks on this list and start looking for the newest companies that fit these criteria. It's easy to do. And it could help you find your next big winner. Start screening for these companies today with a free trial to the Research Wizard. You can do it. Click here to sign up for a free trial to the Research Wizard today. Want more articles from this author? Scroll up to the top of this article and click the FOLLOW AUTHOR button to get an email each time a new article is published. Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. Disclosure: Performance information for Zacks' portfolios and strategies are available at: Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Modine Manufacturing Company (MOD) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Zacks.com featured highlights include QuantumScape, Civeo and Agenus
Zacks.com featured highlights include QuantumScape, Civeo and Agenus

Yahoo

time01-08-2025

  • Business
  • Yahoo

Zacks.com featured highlights include QuantumScape, Civeo and Agenus

For Immediate Release Chicago, IL – August 1, 2025 – Stocks in this week's article are QuantumScape Corp. QS, Civeo Corp. CVEO and Agenus Inc. AGEN. QuantumScape & 2 Other Stocks to Buy for Earnings Acceleration Top executives and analysts focus on consistent earnings growth, which reflects a company's profitability. However, earnings acceleration has an even greater impact on driving up stock prices. Studies show that successful stocks experience a speed-up in earnings before their stock prices increase. To that end, QuantumScape Corp., Civeo Corp. and Agenus Inc. are exhibiting strong earnings acceleration this month. What Is Earnings Acceleration? Earnings acceleration is the incremental growth in a company's earnings per share (EPS). In other words, if a company's quarter-over-quarter earnings growth rate increases within a stipulated time frame, it can be called earnings acceleration. In the case of earnings growth, you pay for something that is already reflected in the stock price. However, earnings acceleration helps spot stocks that haven't yet caught the attention of investors and, once secured, will invariably lead to a rally in the share price. This is because earnings acceleration considers both the direction and magnitude of growth rates. An increasing percentage of earnings growth means that the company is fundamentally sound and has been on the right track for a considerable period. Meanwhile, a sideways percentage of earnings growth indicates a period of consolidation or slowdown, while a decelerating percentage of earnings growth may drag prices down. The above criteria narrowed the universe of around 7,735 stocks to only four. Here are the top three stocks: QuantumScape QuantumScape develops solid-state lithium-metal batteries for electric vehicles in the United States. QuantumScape has a Zacks Rank #2 (Buy). QuantumScape's expected earnings growth rate for the current year is 17% (read more: QuantumScape Vs. NVIDIA: Which Stock Is a Better Buy Now?). Civeo Civeo provides hospitality services for the natural resource industry globally. Civeo has a Zacks Rank #2. CVEO's expected earnings growth rate for the current year is 69.8%. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Agenus Agenus is a clinical-stage biotechnology company that develops therapies to activate immune responses against cancer globally. Agenus has a Zacks Rank #2. AGEN's expected earnings growth rate for the current year is 114.7%. You can sign up now for your 2-week free trial to the Research Wizard and start using this screen in your trading. Further, you can also create your own strategies and test them first before taking the investment plunge. The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out. Click here to sign up for a free trial to the Research Wizard today. For the rest of this Screen of the Week article please visit at: Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. About Screen of the Week created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use. Strong Stocks that Should Be in the News Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>. Follow us on Twitter: Join us on Facebook: Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates. Contact: Jim Giaquinto Company: Phone: 312-265-9268 Email: pr@ Visit: provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit information about the performance numbers displayed in this press release. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Agenus Inc. (AGEN) : Free Stock Analysis Report Civeo Corporation (CVEO) : Free Stock Analysis Report QuantumScape Corporation (QS) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research

Weathering Market Uncertainty? Bet on VIPS, ALKT, FUTU & VRNA Now
Weathering Market Uncertainty? Bet on VIPS, ALKT, FUTU & VRNA Now

Yahoo

time16-07-2025

  • Business
  • Yahoo

Weathering Market Uncertainty? Bet on VIPS, ALKT, FUTU & VRNA Now

The U.S. stock market is expected to remain volatile due to rising inflation pressures fueled by new tariffs and uncertainty around corporate earnings. In this context, creating a curated portfolio of low-beta stocks is a prudent strategy. This provides a safeguard against uncertain market conditions, equipping investors to navigate volatility with greater resilience and foresight. Hence, stocks like Vipshop Holdings Limited VIPS, Alkami Technology Inc ALKT, Futu Holdings Limited FUTU and Verona Pharma plc VRNA are worth betting on. What Does Beta of a Stock Measure? Beta measures the volatility or risk of a particular asset compared to the market. In other words, beta measures the extent of a security's price movement relative to the market. In this article, we are considering the S&P 500 as the market. If a stock has a beta of 1, then the price of the stock will move with the market. So, the stock is more volatile than the market if its beta is more than 1. In the same way, the stock is not as volatile as the market if its beta is less than 1. For example, if the market offers a return of 20%, a stock with a beta of 3 will return 60%, which is overwhelming. Similarly, when the market slips 20%, the stock will sink 60%, which is devastating. Screening Criteria Using Research Wizard: We have taken a beta between 0 and 0.6 as our prime criterion for screening stocks that are less volatile than the market. However, this should not be the only factor to be considered while selecting a winning strategy. We need to take into account other parameters that can add value to the portfolio. Percentage Change in Price in the Last 4 Weeks Greater Than Zero: This ensures that the stocks saw positive price movement over the last month. Average 20-Day Volume Greater Than 50,000: A substantial trading volume ensures that the stocks are easily tradable. Price Greater Than or Equal to $5: They must all be trading at a minimum of $5 or higher. Zacks Rank Equal to 1: Zacks Rank #1 (Strong Buy) stocks indicate that they will significantly outperform the broader U.S. equity market over the next one to three months. You can see the complete list of today's Zacks #1 Rank stocks here. Here are four of the 11 stocks that qualified for the screening: Vipshop Holdings Vipshop Holdings offers products that incentivize customers to come back. One key strategy is the Made for Vipshop program, where more than 200 brands create exclusive products just for Vipshop customers. The products are generally not available anywhere else, but are in high demand among those shoppers. Alkami Technology Alkami Technology is seeing growing interest in its products from both banks and credit unions. The increased demand mainly targets MANTL, a company Alkami recently acquired that offers tools to make it easy for people to open new accounts. Futu Holdings Being a tech-driven player, Futu Holdings is making investing easy and fully online. The company is also upgrading its platform, with the recent update being Futubull AI – a smart assistant that answers investment-related questions quickly and accurately. Verona Pharma Verona Pharma's drug Ohtuvayre is proving to be a game-changer in COPD treatment. It's the first inhaled therapy with a new mechanism of action in more than two decades, combining bronchodilation with non-steroidal anti-inflammatory effects. This dual benefit is helping patients breathe better and reduce lung inflammation without relying on steroids. You can get the rest of the stocks on this list by signing up now for your two-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge. The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out. Click here to sign up for a free trial to the Research Wizard today. Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. Disclosure: Performance information for Zacks' portfolios and strategies are available at: . Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Vipshop Holdings Limited (VIPS) : Free Stock Analysis Report Verona Pharma PLC American Depositary Share (VRNA) : Free Stock Analysis Report Futu Holdings Limited Sponsored ADR (FUTU) : Free Stock Analysis Report Alkami Technology, Inc. (ALKT) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research

Zacks.com featured highlights include Exelixis, Lyft and Kinross Gold
Zacks.com featured highlights include Exelixis, Lyft and Kinross Gold

Yahoo

time30-06-2025

  • Business
  • Yahoo

Zacks.com featured highlights include Exelixis, Lyft and Kinross Gold

Chicago, IL – June 30, 2025 – Stocks in this week's article are Exelixis, Inc. EXEL, Lyft, Inc. LYFT and Kinross Gold Corp. KGC. Stock markets have been experiencing significant volatility of late. This is largely because of geopolitical tensions and the ongoing trade war. These near-term risks have led to expectations of economic slowdown and rising inflation. In such an uncertain environment, retail investors face significant challenges in selecting the right stocks and achieving strong returns. One way to cut short this task is to follow brokers' recommendations. In this regard, stocks like Exelixis, Inc., Lyft, Inc. and Kinross Gold Corp. are worth considering. As brokers directly communicate with top management, they have more insight into what is happening in a particular company. They assess a company's publicly available documents and even attend conference calls. Brokers have more understanding of the overall sector and industry. They place company fundamentals against the current economic backdrop to determine how a particular stock will fare as an investment. When brokers upgrade a stock, one can easily rely on their judgment. Yet, depending on broker upgrades is not enough to build your investment portfolio. A few other factors should be taken into account to ensure steady returns. Alameda, CA-based Exelixis is an oncology-focused biotechnology company that primarily focuses on the discovery, development and commercialization of new drugs for the treatment of difficult-to-treat cancers. Currently, EXEL has four approved drugs in its portfolio. Exelixis' 2025 earnings are expected to rise 32% year over year. EXEL, which currently carries a Zacks Rank #2, has witnessed a 5% upward revision in broker ratings over the past four weeks. Lyft, based in San Francisco, CA, was founded in 2012. LYFT operates multimodal transportation networks in the United States and Canada. LYFT's 2025 earnings are projected to grow 15.8% on a year-over-year basis. Lyft, carrying a Zacks Rank #2 at present, has witnessed a 2.5% upward revision in broker ratings over the past four weeks. Based in Toronto, Canada, Kinross is involved in the exploration and operation of gold mines. KGC ranks among the top 10 gold mining companies globally. Kinross' 2025 earnings are expected to jump 69.1% year over year. KGC, presently carrying a Zacks Rank #2, has witnessed an 8.3% upward revision in broker ratings over the past four weeks. Get the remaining stock on the list and start putting this and other ideas to the test. It can all be done with the Research Wizard stock picking and backtesting software. The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out. Click here to sign up for a free trial of the Research Wizard today. For the rest of this Screen of the Week article please visit at: Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. About Screen of the Week created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use. Strong Stocks that Should Be in the News Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>. Follow us on Twitter: Join us on Facebook: Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates. Contact: Jim Giaquinto Company: Phone: 312-265-9268 Email: pr@ Visit: provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit information about the performance numbers displayed in this press release. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Kinross Gold Corporation (KGC) : Free Stock Analysis Report Exelixis, Inc. (EXEL) : Free Stock Analysis Report Lyft, Inc. (LYFT) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Zacks.com featured highlights include Intuit, Dave and Centrus Energy
Zacks.com featured highlights include Intuit, Dave and Centrus Energy

Yahoo

time20-06-2025

  • Business
  • Yahoo

Zacks.com featured highlights include Intuit, Dave and Centrus Energy

Chicago, IL – June 20, 2025 – Stocks in this week's article are Intuit Inc. INTU, Dave Inc. DAVE and Centrus Energy Corp. LEU. Investors should prioritize profitable companies over loss-making ones to ensure solid returns after covering all costs. We have used accounting ratios to evaluate a company's profitability. There are several profitability ratios, and we have chosen the most successful and commonly used profitability metric to assess a company's bottom-line performance. To that end, Intuit Inc., Dave Inc. and Centrus Energy Corp. have been selected as top picks due to their high net income ratios. The net income ratio provides an accurate measure of a company's profitability level. It shows the percentage of net income relative to total sales revenues. By analyzing the net income ratio, one can assess a firm's effectiveness in addressing both operating and non-operating expenses from its revenues. A higher net income ratio typically indicates a company's capability to generate substantial revenues and manage all business functions successfully. Here are three of the 14 stocks that qualified for the screening: Intuit Intuit offers financial management, compliance and marketing products and services in the United States. The 12-month net profit margin of Intuit is 19.1%. Dave Dave offers financial products and services via its platform in the United States. The 12-month net profit margin of DAVE is 13.8%. Centrus Energy Centrus Energy provides nuclear fuel components to the United States, Belgium, Japan, the Netherlands and globally. The 12-month net profit margin of LEU is 22.6%. You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge. The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out. Click here to sign up for a free trial to the Research Wizard today. For the rest of this Screen of the Week article please visit at: Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. About Screen of the Week created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use. Strong Stocks that Should Be in the News Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>. Follow us on Twitter: Join us on Facebook: Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates. Contact: Jim Giaquinto Company: Phone: 312-265-9268 Email: pr@ Visit: provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit information about the performance numbers displayed in this press release. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Intuit Inc. (INTU) : Free Stock Analysis Report Dave Inc. (DAVE) : Free Stock Analysis Report Centrus Energy Corp. (LEU) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store